Policy and Medicine Compliance Update October 2023 Issue Features: Complex World of Medical Education, FDA Regulation of Laboratory Developed Tests, FDA Post Marketing Requirements, Distinct Roles of Legal and Compliance and Teva’s Generic Price Fixing Settlement Read more
Policy and Medicine Compliance Update August 2023 Issue Features: CMS Open Payments Reporting for 2023, Impact of Life Science Compliance, HHS-OIG revision of compliance guidance, and US Final Regulation for Drug Price Negotiations Read more
Policy and Medicine Compliance Update July 2023 Issue Features: HHS OIG Guidance on Cash Equivalents, Gift Cards and In-kind, Supreme Court Polansky Decision, Rite Aid Arguments, and PBM Legislation Read more